FREE Virtual Study Fair | 1 - 2 March | REGISTER NOW FREE Virtual Study Fair | 1 - 2 March | REGISTER NOW

Queen’s University Belfast, School of Medicine, Dentistry & Biomedical Sciences PhD Projects, Programmes & Scholarships

We have 38 Queen’s University Belfast, School of Medicine, Dentistry & Biomedical Sciences PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

School of Medicine, Dentistry & Biomedical Sciences  Queen’s University Belfast

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 38 Queen’s University Belfast, School of Medicine, Dentistry & Biomedical Sciences PhD Projects, Programmes & Scholarships

PhD saved successfully
Last chance to apply

Inclusive cities: Exploring effective design of safe and welcoming green spaces

  Research Group: Centre for Public Health
The issue of design, safety and wellbeing in green spaces is a key challenge for Belfast and is one of the main barriers to effective roll out of greening strategies for the city. Read more
Last chance to apply

Free School Meals, Diet Quality and Food Insecurity in Secondary School Pupils

  Research Group: Centre for Public Health
Not having enough money to buy food is known as food insecurity and is common in UK children. Free school meals (FSM) are offered to children based on household income. Read more
Last chance to apply

Developing an injury surveillance system in road cycling in order to design and implement injury prevention programmes

  Research Group: Centre for Public Health
The primary aim of this PhD project is to establish a prospective injury surveillance system in collaboration with EF Education-Tibco-SVB, a Women’s World Tour Professional Cycling Team (both in road cycling and cyclocross). Read more
Last chance to apply

Where we live & mental ill-health: utilising linked administrative data to explore the impact of environment on mental ill-health

  Research Group: Centre for Public Health
Mental ill-health is a major public health concern and the environment in which we live can affect this. There is a need to understand which factors about our environment have the greatest influence in order to inform pro-mental health policy and infrastructure. Read more
Last chance to apply

Elucidating the interaction of influenza A virus mRNA with host trafficking and translation machinery during the viral replication cycle

  Research Group: Wellcome-Wolfson Institute for Experimental Medicine
We have an exciting opportunity in the lab for a hard-working PhD candidate to contribute to an EU-funded project from the European Research Council investigating the role of RNA regulation in influenza virus infection. Read more
Last chance to apply

Investigation of the role of the Formyl Peptide Receptor 2 in diabetic retinopathy

  Research Group: Wellcome-Wolfson Institute for Experimental Medicine
Diabetic retinopathy is one of the leading causes of irreversible blindness in diabetic patients. One important factor contributing to this condition is the transcriptional and biosynthetic changes occurring in the retina Müller glial cells (MGCs) exposed to higher concentrations of glucose. Read more

Three-dimensional structural mapping of the retinal neurovascular unit and the influence of diabetes

The aim of this PhD project is to better understand why people with diabetes are at risk of losing their vision. Diabetic retinopathy is a leading cause of visual impairment and blindness in developed countries. Read more

Using computational biology and transcriptional data to identify signaling that contributes to cancer progression

  Research Group: The Patrick G Johnston Centre for Cancer Research
Our group is looking to recruit a PhD candidate, with experience of working with molecular datasets, with an interest in performing translational bioinformatics analyses to understand the nuanced and complex interactions between cancer cells and their microenvironment for major emerging clinical tumour subtypes. . Read more

Using epigenetic modifiers in combination with 5-FU based chemotherapy to elicit tumour specific immune responses and immunogenic cell death in colorectal cancer.

HDAC inhibitors (HDACi) are an emergent class of epigenetic modifying agent (EMA), with multi-modal mechanisms-of-action in both tumour and tumour microenvironment (TME). This project aims to understand how these drugs modulate efficacy of 5-FU-based chemotherapy to counteract transcriptional plasticity and immune evasion that underpins emergence of treatment resistance. Read more

Targeting the ‘Worst of the Worst’ – developing novel treatments for Poor Outcome Triple Negative Breast Cancers.

We will investigate biology driving the aggressive features of Poor Outcome Triple Negative Breast Cancers (PO-TNBCs). PO-TNBCs possess the worst outcomes amongst all breast cancers, with high rates of metastases and chemoresistance. Read more

Filtering Results